Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Biomarker Testing Market?

The scale of the biomarker testing market has drastically amplified in the past few years, with projections suggesting an increase from $17.51 billion in 2024 to $19.75 billion in 2025, creating a compound annual growth rate (CAGR) of 12.8%. Triggers for this significant growth during the historical period include a growing inclination towards personalized medicine, widespread usage of biomarkers in oncology, a surge in chronic diseases, a broadening pool of research funding in the life sciences, and an escalating demand for detecting diseases at an early stage.

What Growth Rate Is Forecasted for the Biomarker Testing Market by 2029?

In the coming years, the biomarker testing market is predicted to experience a rapid expansion, with forecasts suggesting it will reach $31.63 billion in 2029, growing at a compound annual growth rate (CAGR) of 12.5%. This predicted surge in the coming period is due to several factors such as the increasing use of biomarkers in non-cancer related diseases, growing investment in companion diagnostics, the increasing implementation of artificial intelligence within diagnostics, the expansion of point-of-care testing, and greater awareness towards preventive healthcare. Looking at upcoming trends, advancements in sequencing technologies, ongoing innovations in liquid biopsy, evolving developments in multiplex biomarker platforms, innovation in the realm of proteomics and metabolomics, and an increased investment in R&D are anticipated.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

Which Key Companies Are Shaping the Future of the Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Which Factors Are Driving Demand in the Biomarker Testing Industry?

The growth of the biomarker testing market is projected to surge due to the escalating cancer burden. Cancer is a variety of diseases depicted by the deregulated expansion and dissemination of abnormal cells throughout the body. This surge in cancer cases can be attributed to lifestyle habits such as a substandard diet, smoking, lack of physical activity, and overconsumption of alcohol. Biomarker testing proves beneficial in cancer detection by providing early and accurate recognition of disease-specific markers, thereby enhancing diagnostic precision. Personalized treatment plans based on these tests lead to improved patient outcomes and more efficient healthcare management. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in July 2024 that the number of diagnosed cancer cases in Australia hit 160,570 in 2022. This number shows an upsurge of 3,789 cases from the 156,781 cases in 2021. Hence, the escalating burden of cancer is fueling the expansion of the biomarker testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

How Is the Biomarker Testing Market Segmented by Several Divisions?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

What are the Emerging Market Trends Driving the Growth of the Biomarker Testing Industry?

Key businesses in the biomarker testing market, such as Quest Diagnostics Incorporated, are prioritizing the development of innovative solutions like immunohistochemistry (IHC) technology. This focus is aimed at enhancing diagnostic precision, facilitating early detection of diseases and promoting personalized treatment plans. Immunohistochemistry (IHC) technology is a lab procedure that employs antibodies to identify particular proteins in tissue samples, thus assisting in pinpointing and visualizing disease biomarkers for diagnostic and research purposes. In the exemplar case of Quest Diagnostics Incorporated, this US-based medical laboratories company, initiated a fresh tissue-based biomarker test for prostate cancer via its AmeriPath division in July 2023. By leveraging proprietary biomarkers EV1, EV2, and EV3, the new testing improves diagnostic accuracy. It serves an essential clinical function by enabling physicians to accurately identify and distinguish aggressive prostate cancer types, enhances grading consistency, and guides suitable treatment techniques for patients.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Regions Are Driving Growth in the Biomarker Testing Market?

North America was the largest region in the biomarker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24480

This Report Delivers Insight On:

1. How big is the biomarker testing market, and how is it changing globally?

2. Who are the major companies in the biomarker testing market, and how are they performing?

3. What are the key opportunities and risks in the biomarker testing market right now?

4. Which products or customer segments are growing the most in the biomarker testing market?

5. What factors are helping or slowing down the growth of the biomarker testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model